{
  "zip": "M5X 1A4",
  "sector": "Healthcare",
  "longBusinessSummary": "Vaxil Bio Ltd., an immunotherapy biotech company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company's lead product is ImMucin that has completed a Phase I/II clinical trial for the treatment of multiple myeloma. It is also developing a tuberculosis vaccine/treatment and a coronavirus (COVID-19) vaccine. The company has a collaboration agreement with The Tel Aviv Sourasky Medical Center for the company's research program to develop a potential peptide vaccine against COVID-19; and cooperative research and development agreement with U.S. Army Medical Research Institute of Infectious Diseases for testing CorVax for its ability to prevent COVID-19 in mice. The company was founded in 2006 and is headquartered in Toronto, Canada.",
  "city": "Toronto",
  "state": "ON",
  "country": "Canada",
  "companyOfficers": [],
  "website": "http://www.vaxil-bio.com",
  "maxAge": 1,
  "address1": "3400 One First Canadian Place",
  "industry": "Biotechnology",
  "previousClose": 0.31,
  "regularMarketOpen": 0.3065,
  "twoHundredDayAverage": 0.102679566,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.45,
  "navPrice": null,
  "averageDailyVolume10Day": 615188,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.31,
  "fiftyDayAverage": 0.16949181,
  "trailingAnnualDividendRate": null,
  "open": 0.3065,
  "averageVolume10days": 615188,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": -3.609395,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.3034,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 353129,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 45043008,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 237981,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.3034,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 353129,
  "fiftyTwoWeekHigh": 0.75,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.0131,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.45,
  "exchange": "PNK",
  "shortName": "VAXIL BIO LTD (CA)",
  "longName": "Vaxil Bio Ltd.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "VXLLF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_108333814",
  "uuid": "9e7b383f-26e7-3815-92b9-aa2ae181b474",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 115559000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 0.007,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": null,
  "trailingEps": -0.012,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 58.571426,
  "heldPercentInsiders": 0.100600004,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 89474380,
  "enterpriseValue": 34731668,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.3065,
  "logo_url": "https://logo.clearbit.com/vaxil-bio.com"
}